Skip to main content
Article thumbnail
Location of Repository

Disease Rescue and Increased Lifespan in a Model of Cardiomyopathy and Muscular Dystrophy by Combined AAV Treatments

By Carmen Vitiello, Stefania Faraso, Nicolina Cristina Sorrentino, Giovanni Di Salvo, Edoardo Nusco, Gerardo Nigro, Luisa Cutillo, Raffaele CalabrĂ², Alberto Auricchio and Vincenzo Nigro
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). A Common Disease-Associated Missense Mutation in Alpha-Sarcoglycan Fails to Cause Muscular Dystrophy in Mice.
  2. (2005). AAV hybrid serotypes: improved vectors for gene delivery.
  3. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart.
  4. (1989). Association of dystrophin and an integral membrane glycoprotein.
  5. (1996). Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene.
  6. (1993). Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.
  7. (2003). Cardiomyopathy in muscular dystrophies.
  8. (1992). Deficiency of the 50 K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.
  9. (1996). Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.
  10. (2007). Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.
  11. (2007). Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
  12. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
  13. (2003). Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adenoassociated virus-2 vectors.
  14. (2001). Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.
  15. (2006). Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B.
  16. (1998). Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using deltasarcoglycan gene transfer.
  17. (1997). Identification of the Syrian hamster cardiomyopathy gene.
  18. (2005). Molecular and cell biology of the sarcoglycan complex.
  19. (2004). Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.
  20. (1979). Myopathy of hamster dystrophy: history and morphologic aspects.
  21. (1962). New hereditary disease of Syrian hamsters. Primary, generalized polymyopathy and cardiac necrosis.
  22. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
  23. (2007). Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes.
  24. (2002). Orthopedic management of the muscular dystrophies.
  25. (2008). Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.
  26. (2000). Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.
  27. (2006). Recent advances in respiratory care for neuromuscular disease.
  28. (2006). Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.
  29. (2002). Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer.
  30. (2006). Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
  31. (2008). Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.
  32. (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
  33. (2001). Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors.
  34. (2005). Sustained wholebody functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer.
  35. (1999). Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences.
  36. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors.
  37. (1990). The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.
  38. (2002). Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.